Scaling customer development: crowdsourcing the research – Elaine Chen

MIT Sloan Senior Lecturer Elaine Chen

MIT Sloan Senior Lecturer Elaine Chen

From The Huffington Post

In the seminal book “The Four Steps to the Epiphany”, Steve Blank introduces the concept of “customer development” – get out of the building and interview customers. While this is not a new concept – product people with user-centered design training have always done this – this is a huge development in startup-land, where technology used to run amuck.

Challenges with sample size

There is one small problem with customer development. It relies on qualitative research techniques like detailed interviews and observation, which are time consuming and costly.  Additionally, these techniques involve deep interactions with a few individuals, and you always run the risk of talking to the wrong people about the wrong problems.

How do you know whether you can trust your results? One way is to increase sample size – but given each interaction can take a couple of hours all-in, trying to get to 100 conversations quickly becomes daunting.

Read More »

Andrew McAfee and Erik Brynjolfsson discuss their new book, “Machine, Platform, Crowd: Harnessing our Digital Future” June 26, 2017

Erik Brynjolfsson and Andrew McAfee

MIT Sloan’s Erik Brynjolfsson and Andrew McAfee

 

Our latest installment of the MIT Sloan Expert Series includes a live conversation with Andrew McAfee ​and ​Erik Brynjolfsson, co-authors of the new book Machine, Platform, Crowd: Harnessing our Digital Future, which is being hailed as “a must-read road map” for success in the digital economy. The book is a sequel to their bestseller The Second Machine Age.

Harnessing our Digital Future: Machine, Platform Crowd

Beth Comstock, Vice Chair of GE, appears​ on the program to discuss how the company harnesses the wisdom of the crowd for product ​innovations and design.

Sandy Pentland, MIT Professor of Media Arts and Science, also joins us to talk about managerial best practices for navigating this new world of rapidly advancing technology.

 

Using statistics can can improve clinical trials and outcomes – Dimitris Bertsimas

MIT Sloan Professor Dimitris Bertsimas

MIT Sloan Professor Dimitris Bertsimas

From Times Higher Education 

Sometimes science can be personal. When my father, who was living in Greece at the time, was diagnosed with stage IV gastric cancer in 2007, I set out to find the best possible care for him. As is the case with many patients with advanced disease, drug therapy was his best course. So, after unsuccessful surgery in Greece, he came to the US for treatment.

I contacted the most prestigious cancer hospitals in the country and found that they all used different drugs in different treatment regimens to treat advanced gastric cancer. As both a son and a scientist, I was surprised to discover that there was no standard treatment – something I would later realise was true of many different kinds of late-stage cancers.

Read More »

The Businesses That Platforms Are Actually Disrupting – David S. Evans and Richard Schmalensee

MIT Sloan Professor Richard Schmalensee

MIT Sloan Professor Richard Schmalensee

From Harvard Business Review

Platforms are all the rage these days. Powered by online technologies, they are sweeping across the economic landscape, striking down companies large and small. Uber’s global assault on the taxi industry is well known. Many platforms, some household names and others laboring in obscurity, are doing the same in other sectors.

Surveying these changes, you might conclude that if your business isn’t a platform, you had better worry that one is coming your way. Everyone from automakers to plumbers should count their days as traditional businesses. And maybe you should jump on the platform bandwagon too. If it worked for Airbnb, why not you?

Read More »

Reimagining Chile’s healthcare system: Harnessing the power of strategic analytics and Big Data to keep patients healthier for less money – Rafael Epstein, Marcelo Larraguibel, Lee Ullman

Lee Ullmann, Director of the MIT Sloan Latin America Office

Lee Ullmann, Director of the MIT Sloan Latin America Office

From El Mercurio

Economic growth, urbanization, and rising affluence are having a profound impact on the health of Latin Americans. Very little of it is positive, especially in Chile.

While life expectancy has increased faster in Chile than in most OECD countries and income per person has quadrupled over the last quarter-century, great disparities continue to exist between the country’s public and private healthcare systems. Healthcare costs are skyrocketing and many of the country’s public hospitals—especially those in rural areas—face a shortage of general practitioners and family physicians.

The modern Chilean diet—comprised largely of ultra-processed foods and sugary drinks—is taking a toll. One third of Chilean children are overweight or obese; one quarter of Chilean adults are in those categories. Chronic diseases, like diabetes, are increasingly prevalent. Stress-related disorders and mental illnesses are also on the rise, as are rates of alcoholism, tobacco use, and certain types of cancer. Over the last decade suicide has been one of the top 10 causes of death in Chilean men.

Today’s statistics are bleak, but we have hope for the tomorrow. Technological innovations and discoveries, powered by Big Data, hold enormous opportunities for Chile and Latin America overall. To explore this further, we are hosting a conference next month in Santiago—“Strategic Analytics: Changing the Future of Healthcare”—that aims to highlight the many ways in which data and analytics promise to transform the provision of healthcare. The conference is expected to draw hundreds of researchers and leaders from academia, health care, government, and industry.

Our agenda is ambitious. By combining MIT’s expertise in analyzing massive amounts of data and optimizing complex systems with Universidad de Chile’s path-breaking medical research and Virtus Partners’ strategic and operational insights, we aim to unravel the complicated underlying problems that plague the healthcare system.

Of course many countries—including the US—face healthcare challenges. Our hope is that this conference inspires engineers, medical professionals, economists, and technologists from all over the world to see the benefits of working together to improve human health. Our goal is simple: to keep patients healthier for less money.

Progress is afoot. At MIT, researchers have devised algorithms that boost treatment for certain diseases, including diabetes, using a combination of machine learning and electronic medical records. At a time when 1.7 million Chileans, or about 12.3% of the population, have diabetes, this research has important implications.

The dawn of telemedicine—which enables doctors to monitor patients from afar—also holds promise, particularly for patients who live in remote areas. (Chile is a long and skinny country, and about 10% of the population lives in rural areas.) Researchers at the Universidad de Chile’s Medical Informatics and Telemedicine Center are using sensors and other devices to monitor patients’ blood pressure, heart rate, weight, and blood sugar levels from great distances. Technologists at the MIT Media Lab are finding new ways to apply emotion technology and wearable devices to help sufferers with autism, anxiety, and epilepsy manage their symptoms.

Researchers are also finding new ways to contain medical costs. Using Big Data to measure returns of healthcare spending, economists are able to help hospitals uncover best practices and align incentives to improve the quality of the care they provide. This has special relevance to Chile. The country’s Fondo Nacional de Salud (FONASA) struggles with overwhelming management challenges and increasing costs. Meanwhile, access to high-quality technology and healthcare services is still limited to the wealthy.

The promise of Big Data is immense, but so, too, are its perils. Many questions remain: How do we ensure that patient data stays both confidential and secure? How do we safeguard against Big Data applications creating even more disparities between the rich and poor, and instead use it to build a more equitable healthcare system for all? And how should governments cope with managing the high costs of aging populations?

These are big challenges and nothing will be solved overnight. Our hope is that the conference will point to new ideas and solutions that improve patient health for generations to come.

Read the original blog post at El Mercurio.

Lee Ullmann is the Director of the MIT Sloan Latin America Office.

Rafael Epstein is the Provost of Universidad de Chile.

Marcelo Larraguibel is the Founder of Virtus Partners, the management consultancy, and an Advisory Council Member of the MIT Sloan Latin America Office (MSLAO).